Advances in the mechanisms of vascular calcification in chronic kidney disease.

Autor: Wang Z; Department of Cardiology, Affiliated Hospital of Jiangsu University, Zhenjiang, China.; Institute of Cardiovascular Diseases, Jiangsu University, Zhenjiang, China., Gui Z; Department of Cardiology, Affiliated Hospital of Jiangsu University, Zhenjiang, China.; Institute of Cardiovascular Diseases, Jiangsu University, Zhenjiang, China., Zhang L; Department of Radiology, Affliated Hospital of Jiangsu University, Zhenjiang, China., Wang Z; Department of Cardiology, Affiliated Hospital of Jiangsu University, Zhenjiang, China.; Institute of Cardiovascular Diseases, Jiangsu University, Zhenjiang, China.
Jazyk: angličtina
Zdroj: Journal of cellular physiology [J Cell Physiol] 2024 Oct 11, pp. e31464. Date of Electronic Publication: 2024 Oct 11.
DOI: 10.1002/jcp.31464
Abstrakt: Vascular calcification (VC) is common in patients with advanced chronic kidney disease (CKD).A series of factors, such as calcium and phosphorus metabolism disorders, uremic toxin accumulation, inflammation and oxidative stress and cellular senescence, cause osteoblast-like differentiation of vascular smooth muscle cells, secretion of extracellular vesicles, and imbalance of calcium regulatory factors, which together promote the development of VC in CKD. Recent advances in epigenetics have provided better tools for the investigation of VC etiology and new approaches for finding more accurate biomarkers. These advances have not only deepened our understanding of the pathophysiological mechanisms of VC in CKD, but also provided valuable clues for the optimization of clinical predictors and the exploration of potential therapeutic targets. The aim of this article is to provide a comprehensive overview of the pathogenesis of CKD VC, especially the new advances made in recent years, including the various key factors mentioned above. Through the comprehensive analysis, we expect to provide a solid theoretical foundation and research direction for future studies targeting the specific mechanisms of CKD VC, the establishment of clinical predictive indicators and the development of potential therapeutic strategies.
(© 2024 Wiley Periodicals LLC.)
Databáze: MEDLINE
Externí odkaz: